What Is Colorectal Cancer?
Colorectal cancer (CRC) is the third most diagnosed cancer, accounting for about 10% of cancers. It’s also the second leading cause of cancer deaths globally (1). As the role of targeted therapy in CRC is evolving, guidelines have expanded their recommendations regarding biomarker testing. Currently, detection of various gene alterations, such as KRAS, NRAS and BRAF mutations, HER2 amplifications, microsatellite instability (MSI), and mismatch repair deficient (MMR) status are recommended (2). As such, Cerba Research can provide a wide range of specialty and safety testing to your existing central laboratory CRC processes. Contact us to learn more.
Colorectal Cancer